MISTRAL

  • Research type

    Research Study

  • Full title

    Multimodal Imaging and Stereotactic Radiosurgery Ablation (of Metastatic) Lesions

  • IRAS ID

    250563

  • Contact name

    Tomasz Matys

  • Contact email

    tm418@cam.ac.uk

  • Sponsor organisation

    Cambridge University Hospitals NHS Foundation Trust and the University of CambridgeCambridge Univers

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    Stereotatic radiosurgery (SRS) is a novel, non-invasive technique to treat brain metastases in patients with cancer, with effectiveness comparable with surgical resection. However, a proportion of metastases may not respond to treatment, and it is currently not possible to predict immediately after treatment if this has been effective . In this study, we plan to test if we can observe changes in diffusion parameters, sodium concentration and blood flow on magnetic resonance imaging (MRI) scans performed after SRS in order to establish if we these could potentially be used to predict response. This is a pilot/feasibilty study which will help us design future studies on this subject.

  • REC name

    South West - Cornwall & Plymouth Research Ethics Committee

  • REC reference

    19/SW/0016

  • Date of REC Opinion

    23 Jan 2019

  • REC opinion

    Favourable Opinion